The DOI matches its Crossref record; 617 of the 617 references it cites were found in a registry or an index.
Bioactive lipids, inflammation and chronic diseases
Abstract
Endogenous bioactive lipids are part of a complex network that modulates a plethora of cellular and molecular processes involved in health and disease, of which inflammation represents one of the most prominent examples. Inflammation serves as a well-conserved defence mechanism, triggered in the event of chemical, mechanical or microbial damage, that is meant to eradicate the source of damage and restore tissue function. However, excessive inflammatory signals, or impairment of pro-resolving/anti-inflammatory pathways leads to chronic inflammation, which is a hallmark of chronic pathologies. All main classes of endogenous bioactive lipids - namely eicosanoids, specialized pro-resolving lipid mediators, lysoglycerophopsholipids and endocannabinoids - have been consistently involved in the chronic inflammation that characterises pathologies such as cancer, diabetes, atherosclerosis, asthma, as well as autoimmune and neurodegenerative disorders and inflammatory bowel diseases. This review gathers the current knowledge concerning the involvement of endogenous bioactive lipids in the pathogenic processes of chronic inflammatory pathologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–400 of 617
Inflammation, Cancer and Oxidative Lipoxygenase Activity are Intimately Linked
Wisastra, R., & Dekker, F. (2014) · Cancers · doi:10.3390/cancers6031500 · Cited by 196
Fredman, G., Ozcan, L., Spolitu, S., Hellmann, J., Spite, M., Backs, J., & Tabas, I. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410851111 · Cited by 193
Angioplasty triggers intracoronary leukotrienes and lipoxin A4. Impact of aspirin therapy.
Brezinski, D. A., Nesto, R. W., & Serhan, C. N. (1992) · Circulation · doi:10.1161/01.cir.86.1.56 · Cited by 193
Endocannabinoid signal in the gut controls dietary fat intake
DiPatrizio, N. V., Astarita, G., Schwartz, G., Li, X., & Piomelli, D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104675108 · Cited by 192
Krashia, P., Cordella, A., Nobili, A., La Barbera, L., Federici, M., Leuti, A., Campanelli, F., Natale, G., Marino, G., Calabrese, V., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11928-w · Cited by 188
Self-citationThe Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer
Hait, N. C., & Maiti, A. (2017) · Mediators of Inflammation · doi:10.1155/2017/4806541 · Cited by 187
A role for sphingosine kinase 1 in dextran sulfate sodium‐induced colitis
Snider, A. J., Kawamori, T., Bradshaw, S. G., Orr, K. A., Gilkeson, G. S., Hannun, Y. A., & Obeid, L. M. (2009) · The FASEB Journal · doi:10.1096/fj.08-118109 · Cited by 186
White, P. J., Arita, M., Taguchi, R., Kang, J. X., & Marette, A. (2010) · Diabetes · doi:10.2337/db10-0054 · Cited by 185
John, S., Luben, R., Shrestha, S. S., Welch, A., Khaw, K.-T., & Hart, A. R. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283352d05 · Cited by 184
Lipoxins and aspirin-triggered lipoxins in resolution of inflammation
Romano, M., Cianci, E., Simiele, F., & Recchiuti, A. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.083 · Cited by 183
Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis
Storr, M. A., Keenan, C. M., Zhang, H., Patel, K. D., Makriyannis, A., & Sharkey, K. A. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20960 · Cited by 183
The pathogenesis of COPD and IPF: Distinct horns of the same devil?
Chilosi, M., Poletti, V., & Rossi, A. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-3 · Cited by 183
BACE1 activity is modulated by cell-associated sphingosine-1-phosphate
Takasugi, N., Sasaki, T., Suzuki, K., Osawa, S., Isshiki, H., Hori, Y., Shimada, N., Higo, T., Yokoshima, S., Fukuyama, T., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6467-10.2011 · Cited by 181
Leukotriene receptors as potential therapeutic targets
Yokomizo, T., Nakamura, M., & Shimizu, T. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97946 · Cited by 181
Identification and Actions of the Maresin 1 Metabolome in Infectious Inflammation
Colas, R. A., Dalli, J., Chiang, N., Vlasakov, I., Sanger, J. M., Riley, I. R., & Serhan, C. N. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600837 · Cited by 180
COX‐2 and Neurodegeneration in Parkinson's Disease
TEISMANN, P., VILA, M., CHOI, D. ‐., TIEU, K., WU, D. C., JACKSON‐LEWIS, V., & PRZEDBORSKI, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07482.x · Cited by 178
Babaev, V. R., Yancey, P. G., Ryzhov, S. V., Kon, V., Breyer, M. D., Magnuson, M. A., Fazio, S., & Linton, M. F. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000173413.31789.1a · Cited by 178
Endocannabinoids, Related Compounds and Their Metabolic Routes
Fezza, F., Bari, M., Florio, R., Talamonti, E., Feole, M., & Maccarrone, M. (2014) · Molecules · doi:10.3390/molecules191117078 · Cited by 177
Self-citationProstaglandin E2 Regulates Tumor Angiogenesis in Prostate Cancer
Jain, S., Chakraborty, G., Raja, R., Kale, S., & Kundu, G. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6689 · Cited by 177
Lipoxygenases and their involvement in programmed cell death
Maccarrone, M., Melino, G., & Finazzi-Agro, A. (2001) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400908 · Cited by 176
Self-citationProresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis
Norling, L. V., Headland, S. E., Dalli, J., Arnardottir, H. H., Haworth, O., Jones, H. R., Irimia, D., Serhan, C. N., & Perretti, M. (2016) · JCI Insight · doi:10.1172/jci.insight.85922 · Cited by 174
Boosting Inflammation Resolution in Atherosclerosis
Fredman, G., & Tabas, I. (2017) · The American Journal of Pathology · doi:10.1016/j.ajpath.2017.01.018 · Cited by 174
Cyclooxygenase-2: a potential target in breast cancer
Wang, D., & DuBois, R. N. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.01.008 · Cited by 172
Skoura, A., Michaud, J., Im, D.-S., Thangada, S., Xiong, Y., Smith, J. D., & Hla, T. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.213496 · Cited by 170
Cannabinoids and autoimmune diseases: A systematic review
Katchan, V., David, P., & Shoenfeld, Y. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.02.008 · Cited by 169
Macrophage dysfunction in the pathogenesis and treatment of asthma
Fricker, M., & Gibson, P. G. (2017) · European Respiratory Journal · doi:10.1183/13993003.00196-2017 · Cited by 169
Storr, M. A., Keenan, C. M., Emmerdinger, D., Zhang, H., Yüce, B., Sibaev, A., Massa, F., Buckley, N. E., Lutz, B., Göke, B., et al. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0359-6 · Cited by 168
Ajuebor, M. N., Singh, A., & Wallace, J. L. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.1.g238 · Cited by 168
Protectin D1 n-3 DPA and resolvin D5 n-3 DPA are effectors of intestinal protection
Gobbetti, T., Dalli, J., Colas, R. A., Federici Canova, D., Aursnes, M., Bonnet, D., Alric, L., Vergnolle, N., Deraison, C., Hansen, T. V., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617290114 · Cited by 168
Terawaki, K., Yokomizo, T., Nagase, T., Toda, A., Taniguchi, M., Hashizume, K., Yagi, T., & Shimizu, T. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4217 · Cited by 167
Lemaître, R. N., Jensen, P. N., Hoofnagle, A. N., McKnight, B., Fretts, A. M., King, I. B., Siscovick, D. S., Psaty, B. M., Heckbert, S. R., Mozaffarian, D., et al. (2019) · Circulation Heart Failure · doi:10.1161/circheartfailure.118.005708 · Cited by 167
Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes
Roche, R., Hoareau, L., Bes-Houtmann, S., Gonthier, M.-P., Laborde, C., Baron, J.-F., Haffaf, Y., Cesari, M., & Festy, F. (2006) · Histochemistry and Cell Biology · doi:10.1007/s00418-005-0127-4 · Cited by 166
Kitano, M., Hla, T., Sekiguchi, M., Kawahito, Y., Yoshimura, R., Miyazawa, K., Iwasaki, T., & Sano, H. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21668 · Cited by 165
Potential of anti-inflammatory agents for treatment of atherosclerosis
Chistiakov, D. A., Melnichenko, A. A., Grechko, A. V., Myasoedova, V. A., & Orekhov, A. N. (2018) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2018.01.008 · Cited by 165
Medeiros, R., Kitazawa, M., Passos, G. F., Baglietto-Vargas, D., Cheng, D., Cribbs, D. H., & LaFerla, F. M. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.01.051 · Cited by 163
Ha, C. Y., Kim, J. Y., Paik, J. K., Kim, O. Y., Paik, Y., Lee, E. J., & Lee, J. H. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04244.x · Cited by 162
The role of prostaglandin E2 in human vascular inflammation
Gomez, I., Foudi, N., Longrois, D., & Norel, X. (2013) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2013.04.004 · Cited by 162
Cardiovascular effects of cyclooxygenase‐2 inhibitors: a mechanistic and clinical perspective
Patrono, C. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13048 · Cited by 162
Role of the endocannabinoid system in diabetes and diabetic complications
Gruden, G., Barutta, F., Kunos, G., & Pacher, P. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13226 · Cited by 161
Aspirin-triggered proresolving mediators stimulate resolution in cancer
Gilligan, M. M., Gartung, A., Sulciner, M. L., Norris, P. C., Sukhatme, V. P., Bielenberg, D. R., Huang, S., Kieran, M. W., Serhan, C. N., & Panigrahy, D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804000116 · Cited by 161
Mukhopadhyay, P., Pan, H., Rajesh, M., Bátkai, S., Patel, V., Harvey-White, J. D., Mukhopadhyay, B., Haskó, G., Gao, B., Mackie, K., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00769.x · Cited by 160
Endocannabinoid signalling in innate and adaptive immunity
Chiurchiù, V., Battistini, L., & Maccarrone, M. (2015) · Immunology · doi:10.1111/imm.12441 · Cited by 159
Self-citationMicroglia activation states and cannabinoid system: Therapeutic implications
Mecha, M., Carrillo-Salinas, F. J., Feliú, A., Mestre, L., & Guaza, C. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.06.011 · Cited by 159
Tellis, C. C., & Tselepis, A. D. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.02.015 · Cited by 158
Leclercq, A., Houard, X., Philippe, M., Ollivier, V., Sebbag, U., Meilhac, O., & Michel, J.-B. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1106671 · Cited by 158
Wu, X., Li, X., Fu, Q., Cao, Q., Chen, X., Wang, M., Yu, J. Z., Long, J., Yao, J., Liu, H., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20160903 · Cited by 158
Keul, P., Tölle, M., Lucke, S., Lipinski, K. V. W., Heusch, G., Schuchardt, M., van der Giet, M., & Levkau, B. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000254679.42583.88 · Cited by 157
Horrillo, R., González‐Périz, A., Martínez‐Clemente, M., López‐Parra, M., Ferré, N., Titos, E., Morán‐Salvador, E., Deulofeu, R., Arroyo, V., & Clària, J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901355 · Cited by 157
Roles of sphingosine-1-phosphate signaling in cancer
Wang, P., Yuan, Y., Lin, W., Zhong, H., Xu, K., & Qi, X. (2019) · Cancer Cell International · doi:10.1186/s12935-019-1014-8 · Cited by 157
Mitochondrial Ceramide-Rich Macrodomains Functionalize Bax upon Irradiation
Lee, H., Rotolo, J. A., Mesicek, J., Peñate-Medina, T., Rimner, A., Liao, W., Yin, X., Ragupathi, G., Ehleiter, D., Gulbins, E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019783 · Cited by 156
Anti‐tumour actions of cannabinoids
Hinz, B., & Ramer, R. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14426 · Cited by 155
Macrophage Sphingomyelin Synthase 2 Deficiency Decreases Atherosclerosis in Mice
Liu, J., Huan, C., Chakraborty, M., Zhang, H., Lü, D., Kuo, M., Cao, G., & Jiang, X. (2009) · Circulation Research · doi:10.1161/circresaha.109.194613 · Cited by 153
Prostacyclin among prostanoids.
Gryglewski, R. J. (2008) · PubMed · Cited by 151
Prostaglandin H Synthetase‐Mediated Metabolism of Dopamine: Implication for Parkinson's Disease
Mattammal, M. B., Strong, R., Lakshmi, V. M., Chung, H. D., & Stephenson, A. H. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041645.x · Cited by 151
Labour induction with prostaglandins: a systematic review and network meta-analysis
Alfirević, Ž., Keeney, E., Dowswell, T., Welton, N. J., Dias, S., Jones, L. V., Navaratnam, K., & Caldwell, D. M. (2015) · BMJ · doi:10.1136/bmj.h217 · Cited by 150
Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy
Barutta, F., Corbelli, A., Mastrocola, R., Gambino, R., Marzo, V. D., Pinach, S., Rastaldi, M. P., Perin, P. C., & Gruden, G. (2010) · Diabetes · doi:10.2337/db09-1336 · Cited by 149
The Endocannabinoid System: A Target for Cancer Treatment
Laezza, C., Pagano, C., Navarra, G., Pastorino, O., Proto, M., Fiore, D., Piscopo, C., Gazzerro, P., & Bifulco, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030747 · Cited by 149
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction
Wagner, J. A., Hu, K., Bauersachs, J. K., Karcher, J. C., Wiesler, M., Goparaju, S. K., Kunos, G., & Ertl, G. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01671-0 · Cited by 148
Marušić, S., Leach, M. W., Pelker, J. W., Azoitei, M. L., Uozumi, N., Cui, J., Shen, M. W. H., DeClercq, C., Miyashiro, J. S., Carito, B. A., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050665 · Cited by 148
DiPatrizio, N. V. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2016.0001 · Cited by 148
Resolvin D3 Is Dysregulated in Arthritis and Reduces Arthritic Inflammation
Arnardottir, H. H., Dalli, J., Norling, L. V., Colas, R. A., Perretti, M., & Serhan, C. N. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502268 · Cited by 147
Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy
Jourdan, T., Szanda, G., Rosenberg, A. Z., Tam, J., Earley, B. J., Godlewski, G., Çınar, R., Liu, Z., Liu, J., Ju, C., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419901111 · Cited by 145
Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy
Barutta, F., Piscitelli, F., Pinach, S., Bruno, G., Gambino, R., Rastaldi, M. P., Salvidio, G., Marzo, V. D., Perin, P. C., & Gruden, G. (2011) · Diabetes · doi:10.2337/db10-1809 · Cited by 145
The Coordination of Prostaglandin E2 Production by Sphingosine-1-phosphate and Ceramide-1-phosphate
Pettus, B. J., Kitatani, K., Chalfant, C. E., Taha, T. A., Kawamori, T., Bielawski, J., Obeid, L. M., & Hannun, Y. A. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008722 · Cited by 144
Monoacylglycerol Lipase Controls Endocannabinoid and Eicosanoid Signaling and Hepatic Injury in Mice
Cao, Z., Mulvihill, M. M., Mukhopadhyay, P., Xu, H., Erdélyi, K., Hao, E., Holovac, E., Haskó, G., Cravatt, B. F., Nomura, D. K., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.12.028 · Cited by 144
The emerging role of the endocannabinoid system in cardiovascular disease
Pacher, P., & Steffens, S. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0145-8 · Cited by 142
Nunemaker, C. S., Chen, M., Pei, H., Kimble, S. D., Keller, S. R., Carter, J. D., Yang, Z., Smith, K. M., Wu, R., Bevard, M. H., et al. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90371.2008 · Cited by 141
Chiurchiù, V., van der Stelt, M., Centonze, D., & Maccarrone, M. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.10.007 · Cited by 140
Self-citationDalli, J., & Serhan, C. N. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14336 · Cited by 138
Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis
Dodge, J. C., Treleaven, C. M., Pacheco, J., Cooper, S., Bao, C., Abraham, M., Cromwell, M. A., Sardi, S. P., Chuang, W., Sidman, R. L., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508767112 · Cited by 138
Human lupus T cells resist inactivation and escape death by upregulating COX-2
Xu, L., Li, Z., Yi, Y., Kang, H.-K., & Datta, S. K. (2004) · Nature Medicine · doi:10.1038/nm1005 · Cited by 138
Targeted lipidomics reveals mPGES-1-PGE2 as a therapeutic target for multiple sclerosis
Kihara, Y., Matsushita, T., Kita, Y., Uematsu, S., Akira, S., Kira, J., Ishii, S., & Shimizu, T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906891106 · Cited by 137
Autotaxin in Pathophysiology and Pulmonary Fibrosis
Ninou, I., Magkrioti, C., & Aidinis, V. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00180 · Cited by 137
Carneiro, A. B., Iaciura, B. M. F., Nohara, L. L., Lopes, C. D., Cordero, E. M., Mariano, V. S., Bozza, P. T., Lopes, U. G., Atella, G. C., de Almeida, I. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076233 · Cited by 136
Sumariwalla, P. F., Gallily, R., Tchilibon, S., Fride, E., Mechoulam, R., & Feldmann, M. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20050 · Cited by 134
Pyne, N. J., McNaughton, M., Boomkamp, S. D., MacRitchie, N. A., Evangelisti, C., Martelli, A. M., Jiang, H., Ubhi, S., & Pyne, S. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2015.09.001 · Cited by 134
Phospholipase A2 catalysis and lipid mediator lipidomics
Mouchlis, V. D., & Dennis, E. A. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.08.010 · Cited by 134
Lipoxin A4 Regulates Bronchial Epithelial Cell Responses to Acid Injury
Bonnans, C., Fukunaga, K., Levy, M. A., & Levy, B. D. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051056 · Cited by 133
Eicosanoids, β-cell function, and diabetes
Luo, P., & Wang, M.-H. (2011) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2011.06.001 · Cited by 131
Oshima, H., Hioki, K., Popivanova, B. K., Oguma, K., van Rooijen, N., Ishikawa, T., & Oshima, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.11.007 · Cited by 131
Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct‐ligated rats
Gaskari, S. A., Liu, H., Moezi, L., Li, Y., Baik, S. K., & Lee, S. S. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706331 · Cited by 130
Mice Deficient in Group IV Cytosolic Phospholipase A2 Are Resistant to MPTP Neurotoxicity
Klivènyi, P., Beal, M. F., Ferrante, R. J., et al. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71062634.x · Cited by 129
Eicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and Stroke
Capra, V., Bäck, M., Barbieri, S. S., Camera, M., Tremoli, E., & Rovati, G. E. (2012) · Medicinal Research Reviews · doi:10.1002/med.21251 · Cited by 129
Role of Sphingolipids in the Pathobiology of Lung Inflammation
Ghidoni, R., Caretti, A., & Signorelli, P. (2015) · Mediators of Inflammation · doi:10.1155/2015/487508 · Cited by 129
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
Moreno, E., Cavic, M. R., Krivokuća, A., Casadó, V., & Canela, E. I. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00339 · Cited by 129
Agudo, J., Martín, M., Roca, C., Molas, M., Bura, S. A., Zimmer, A., Bosch, F., & Maldonado, R. J. (2010) · Diabetologia · doi:10.1007/s00125-010-1894-6 · Cited by 128
van Doorn, R., Nijland, P. G., Dekker, N., Witte, M. E., Pinheiro, M. A. L., Hof, B. V. H., Kooij, G., Reijerkerk, A., Dijkstra, C. D., van der Valk, P., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1014-4 · Cited by 127
Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer
Pérez-Gómez, E., Andradas, C., Blasco-Benito, S., Caffarel, M. M., García-Taboada, E., Villa‐Morales, M., Moreno, E., Hamann, S., Martín-Villar, E., Flores, J. M., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv077 · Cited by 127
Prostanoids as Regulators of Innate and Adaptive Immunity
Hirata, T., & Narumiya, S. (2012) · Advances in immunology · doi:10.1016/b978-0-12-394300-2.00005-3 · Cited by 126
CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 Mice
Aso, E., Palomer, E., Juvés, S., Maldonado, R. J., Muñoz, F. J., & Ferrer, I. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111862 · Cited by 125
The importance of the lipoxygenase-hepoxilin pathway in the mammalian epidermal barrier
Muñoz‐Garcia, A., Thomas, C. P., Keeney, D. S., Zheng, Y., & BRASH, A. R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.08.020 · Cited by 125
Role of Prostaglandins in Neuroinflammatory and Neurodegenerative Diseases
Lima, I. V. D. A., Bastos, L. F. S., Limborço‐Filho, M., Fiebich, B. L., & de Oliveira, A. C. P. (2012) · Mediators of Inflammation · doi:10.1155/2012/946813 · Cited by 125
A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis
Hernández‐Torres, G., Cipriano, M., Hedén, E., Björklund, E., Canales, Á., Zian, D., Feliú, A., Mecha, M., Guaza, C., Fowler, C. J., et al. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201407807 · Cited by 125
Janiak, P., Poirier, B., Bidouard, J., Cadrouvele, C., Pierre, F., Gouraud, L., Barbosa, I., Dedio, J., Maffrand, J., Fur, G. L., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002540 · Cited by 124
Arehart, E. J., Stitham, J., Asselbergs, F. W., Douville, K. L., MacKenzie, T. A., Fetalvero, K. M., Gleim, S., Kasza, Z., Rao, Y., Martel, L., et al. (2008) · Circulation Research · doi:10.1161/circresaha.107.165936 · Cited by 124
Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse
Cheng, J., Bai, A., Beckham, T. H., Marrison, S. T., Yount, C. L., Young, K., Lü, P., Bartlett, A. M., Wu, B. X., Keane, B. J., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64791 · Cited by 124
Dol-Gleizes, F., Paumelle, R., Visentin, V., Marés, A.-M., Desitter, P., Hennuyer, N., Gilde, A. J., Staels, B., Schaeffer, P., & Bono, F. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.168757 · Cited by 123
Bäck, M., Sultan, A., Овчинникова, О. А., & Hansson, G. K. (2007) · Circulation Research · doi:10.1161/01.res.0000264498.60702.0d · Cited by 123
Kooij, G., Troletti, C. D., Leuti, A., Norris, P. C., Riley, I. R., Albanese, M., Ruggieri, S., Libreros, S., van der Pol, S. M. A., Hof, B. V. H., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.219519 · Cited by 123
Self-citationThe gastrointestinal tract – a central organ of cannabinoid signaling in health and disease
Hasenoehrl, C., Taschler, U., Storr, M., & Schicho, R. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12931 · Cited by 121
Xia, Q., Hu, Q., Wang, H., Yang, H., Gao, F., Ren, H., Chen, D., Fu, C., Zheng, L. P., Zhen, X., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.69 · Cited by 119
Oyeniran, C., Sturgill, J., Hait, N. C., Huang, W., Avni, D., Maceyka, M. W., Newton, J. C., Allegood, J. C., Montpetit, A. J., Conrad, D. H., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.02.031 · Cited by 119
Hansen, T. V., Vik, A., & Serhan, C. N. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01582 · Cited by 119
Bcl2L13 is a ceramide synthase inhibitor in glioblastoma
Jensen, S. A., Calvert, A. E., Volpert, G., Kouri, F. M., Hurley, L., Luciano, J. P., Wu, Y., Chalastanis, A., Futerman, A. H., & Stegh, A. H. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316700111 · Cited by 118
Bátkai, S., Mukhopadhyay, P., Harvey-White, J. D., Kechrid, R., Pacher, P., & Kunos, G. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00538.2007 · Cited by 118
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution
Skaper, S. D., Facci, L., Barbierato, M., Zusso, M., Bruschetta, G., Impellizzeri, D., Cuzzocrea, S., & Giusti, P. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9253-8 · Cited by 117
Lipoxin A 4 attenuates adipose inflammation
Börgeson, E., McGillicuddy, F. C., Harford, K. A., Corrigan, N., Higgins, D. F., MADERNA, P., Roche, H. M., & Godson, C. (2012) · The FASEB Journal · doi:10.1096/fj.12-208249 · Cited by 117
An Inflammatory Mediator, Prostaglandin E2, in Colorectal Cancer
Wang, D., & DuBois, R. N. (2013) · The Cancer Journal · doi:10.1097/ppo.0000000000000003 · Cited by 117
López‐Vicario, C., Rius, B., Alcaraz‐Quiles, J., García‐Alonso, V., Lopategi, A., Titos, E., & Clària, J. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.092 · Cited by 116
Chan, P., Hsiao, F., Chang, H., Wabitsch, M., & Hsieh, P. (2016) · The FASEB Journal · doi:10.1096/fj.201500127 · Cited by 116
Towards targeting resolution pathways of airway inflammation in asthma
Barnig, C., Frossard, N., & Levy, B. D. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.01.004 · Cited by 116
Horváth, B., Magid, L., Mukhopadhyay, P., Bátkai, S., Rajesh, M., Park, O., Tanchian, G., Gao, R. Y., Goodfellow, C. E., Glass, M., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01381.x · Cited by 115
Peskar, B. M., Dreyling, K. W., Peskar, B. A., May, B., & Goebell, H. (1986) · Inflammation Research · doi:10.1007/bf01965001 · Cited by 115
MPP + ‐induced COX‐2 activation and subsequent dopaminergic neurodegeneration
Wang, T., Pei, Z., Zhang, W., Liu, B., Langenbach, R. I., Lee, C., Wilson, B. C., Reece, J. M., Miller, D. S., & Hong, J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2457fje · Cited by 114
Tran, P. O. T., Gleason, C. E., & Robertson, R. P. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1772 · Cited by 114
Molecular Mechanisms of High Glucose-Induced Cyclooxygenase-2 Expression in Monocytes
Shanmugam, N., Gonzalo, I. T. G., & Natarajan, R. D. (2004) · Diabetes · doi:10.2337/diabetes.53.3.795 · Cited by 112
EP4 receptor as a new target for bronchodilator therapy
Buckley, J., Birrell, M. A., Maher, S. A., Nials, A. T., Clarke, D. L., & Belvisi, M. (2011) · Thorax · doi:10.1136/thx.2010.158568 · Cited by 112
KATUGAMPOLA, S. D., & Davenport, A. P. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704416 · Cited by 111
Impaired Sphingolipid Synthesis in the Respiratory Tract Induces Airway Hyperreactivity
Worgall, T. S., Veerappan, A., Sung, B., Kim, B. I., Weiner, E., Bholah, R., Silver, R. B., Jiang, X., & Worgall, S. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005765 · Cited by 111
Sphingosine kinase 1 regulates adipose proinflammatory responses and insulin resistance
Wang, J., Badeanlou, L., Bielawski, J., Ciaraldi, T. P., & Samad, F. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00549.2013 · Cited by 110
Prostaglandins and Rheumatoid Arthritis
Fattahi, M. J., & Mirshafiey, A. (2012) · Arthritis · doi:10.1155/2012/239310 · Cited by 110
Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development
Valdés-Rives, S. A., & González‐Arenas, A. (2017) · Mediators of Inflammation · doi:10.1155/2017/9173090 · Cited by 110
SMPD1 mutations, activity, and α‐synuclein accumulation in Parkinson's disease
Alcalay, R. N., Mallett, V., Vanderperre, B., Tavassoly, O., Dauvilliers, Y., Wu, R. Y. J., Ruskey, J. A., Leblond, C. S., Ambalavanan, A., Laurent, S. B., et al. (2019) · Movement Disorders · doi:10.1002/mds.27642 · Cited by 110
Requirement for Leukotriene B4 Receptor 1 in Allergen-induced Airway Hyperresponsiveness
Miyahara, N., Takeda, K., Miyahara, S., Matsubara, S., Koya, T., Joetham, A., Krishnan, E., Dakhama, A., Haribabu, B., & Gelfand, E. W. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200502-205oc · Cited by 109
Metabolomic signatures associated with disease severity in multiple sclerosis
Villoslada, P., Alonso, C., Agirrezabal, I., Kotelnikova, E. A., Zubizarreta, I., Valdeolivas, I. P., Saiz, A., Comabella, M., Montalbán, X., Villar, L. M., et al. (2017) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000321 · Cited by 108
Codagnone, M., Cianci, E., Lamolinara, A., Mari, V. C., Nespoli, A., Isopi, E., Mattoscio, D., Arita, M., Bragonzi, A., Iezzi, M., et al. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.36 · Cited by 108
Kumar, P., Kalonia, H., & Kumar, A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01418.x · Cited by 107
Inflammatory cell expression of cyclooxygenase-2 in the multiple sclerosis lesion
Rose, J. W., Hill, K. E., Watt, H. E., & Carlson, N. G. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.12.021 · Cited by 107
Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages
Croasdell, A., Thatcher, T. H., Kottmann, R. M., Colas, R. A., Dalli, J., Serhan, C. N., Sime, P. J., & Phipps, R. P. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00125.2015 · Cited by 106
Yan, C. H. E. N., Chen, P., Hanaoka, M., Droma, Y., & Kubo, K. (2008) · Respirology · doi:10.1111/j.1440-1843.2008.01365.x · Cited by 106
Kariuki, S. N., Franek, B., Kumar, A. A., Arrington, J., Mikolaitis, R., Utset, T., Jolly, M., Crow, M., Skol, A., & Niewold, T. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3101 · Cited by 106
PGD2/PTGDR2 Signaling Restricts the Self-Renewal and Tumorigenesis of Gastric Cancer
Zhang, B., Bie, Q., Wu, P., Zhang, J., You, B., Shi, H., Qian, H., & Xu, W. (2018) · Stem Cells · doi:10.1002/stem.2821 · Cited by 106
Salic, K., Morrison, M. C., Verschuren, L., Wielinga, P. Y., Wu, L., Kleemann, R., Gjorstrup, P., & Kooistra, T. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.05.001 · Cited by 105
Clark, S., Guy, C. J., Scurr, M. J., Taylor, P. R., Kift-Morgan, A. P., Hammond, V. J., Thomas, C. P., Coles, B., Roberts, G. W., Eberl, M., et al. (2010) · Blood · doi:10.1182/blood-2010-04-278887 · Cited by 105
Slavić, S., Lauer, D., Sommerfeld, M., Kemnitz, U. R., Grzesiak, A., Trappiel, M., Thöne‐Reineke, C., Baulmann, J., Paulis, L., Kappert, K., et al. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1034-0 · Cited by 105
Ahmadi, M., Emery, D. C., & Morgan, D. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1060 · Cited by 105
Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease
Combrinck, M. I. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.063131 · Cited by 105
Sales, K. J., List, T., Boddy, S. C., Williams, A. R. W., Anderson, R. A., Naor, Z., & Jabbour, H. N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0101 · Cited by 104
S1P signaling: new therapies and opportunities
Gonzalez‐Cabrera, P. J., Brown, S. D. M., Studer, S. M., & Rosen, H. (2014) · F1000Prime Reports · doi:10.12703/p6-109 · Cited by 104
Prüß, H., Rosche, B., Sullivan, A. B., Brommer, B., Wengert, O., Gronert, K., & Schwab, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055859 · Cited by 103
GPR101 mediates the pro-resolving actions of RvD5n-3 DPA in arthritis and infections
Flak, M. B., Koenis, D. S., Sobrino, A., Smith, J. T., Pistorius, K., Palmas, F., & Dalli, J. (2019) · Journal of Clinical Investigation · doi:10.1172/jci131609 · Cited by 103
The nuclear membrane organization of leukotriene synthesis
Mandal, A. K., Jones, P., Bair, A. M., Christmas, P., Miller, D. K., Yamin, T.-T. D., Wisniewski, D., Menke, J. G., Evans, J. F., Hyman, B. T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808211106 · Cited by 102
Georas, S. N., Berdyshev, E. V., Hubbard, W. C., Gorshkova, I. A., Usatyuk, P. V., Saatian, B., Myers, A. C., Williams, M. A., Xiao, H., Liu, M., et al. (2006) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2006.02626.x · Cited by 101
Vong, L., Ferraz, J. G., Dufton, N., Panaccione, R., Beck, P. L., Sherman, P. M., Perretti, M., & Wallace, J. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039244 · Cited by 101
Cipollone, F., Fazia, M. L., Iezzi, A., Cuccurullo, C., Cesare, D. D., Ucchino, S., Spigonardo, F., Marchetti, A., Buttitta, F., Paloscia, L., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000177814.41505.41 · Cited by 101
Impaired Resolution of Inflammation in Alzheimer’s Disease: A Review
Whittington, R. A., Planel, E., & Terrando, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01464 · Cited by 100
Xin, Q., Li, J., Dang, J., Bian, X., Shan, S., Yuan, J., Qian, Y., Liu, Z., Liu, G., Yuan, Q., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403028 · Cited by 99
Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis
Dogné, J., Hanson, J., & Praticò, D. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.10.001 · Cited by 99
Thai, T., Patterson, H. C., Pham, D.-H., Kis‐Tóth, K., Kaminski, D. A., & Tsokos, G. C. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317632110 · Cited by 98
Kalyvas, A., Baskakis, C., Magrioti, V., Constantinou‐Kokotou, V., Stephens, D. L., López‐Vales, R., Lu, J., Yong, V. W., Dennis, E. A., Kokotos, G., et al. (2009) · Brain · doi:10.1093/brain/awp002 · Cited by 98
20-HETE promotes glucose-stimulated insulin secretion in an autocrine manner through FFAR1
Tunaru, S., Bonnavion, R., Brandenburger, I., Preussner, J., Thomas, D., Scholich, K., & Offermanns, S. (2018) · Nature Communications · doi:10.1038/s41467-017-02539-4 · Cited by 98
Role of Ceramide in Lipopolysaccharide (LPS)-induced Signaling
MacKichan, M. L., & DeFranco, A. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1767 · Cited by 97
Lipoxin biosynthesis in inflammatory bowel disease
Mangino, M. J., Brounts, L. R., Harms, B., & Heise, C. P. (2005) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2005.10.004 · Cited by 97
Poisson, L., Suhail, H., Singh, J., Datta, I., Đenić, A., Łabuzek, K., Hoda, M. N., Shankar, A., Kumar, A., Cerghet, M., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.679068 · Cited by 97
Arachidonic acid and cancer risk: a systematic review of observational studies
Sakai, M., Kakutani, S., Horikawa, C., Tokuda, H., Kawashima, H., Shibata, H., Okubo, H., & Sasaki, S. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-606 · Cited by 96
Proresolving Lipid Mediators: Endogenous Modulators of Oxidative Stress
Leuti, A., Maccarrone, M., & Chiurchiù, V. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8107265 · Cited by 96
Self-citationCroxford, J. L., Pryce, G., Jackson, S. J., Ledent, C. A., Giovannoni, G., Pertwee, R. G., Yamamura, T., & Baker, D. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.10.024 · Cited by 94
Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis
Fukuda, S., Kohsaka, H., Takayasu, A., Yokoyama, W., Miyabe, C., Miyabe, Y., Harigai, M., Miyasaka, N., & Nanki, T. (2014) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-15-275 · Cited by 93
Dunn, H. C., Ager, R. R., Baglietto‐Vargas, D., Cheng, D., Kitazawa, M., Cribbs, D. H., & Medeiros, R. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141335 · Cited by 93
Lysophosphatidic acid in atherosclerotic diseases
Schober, A., & Siess, W. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02021.x · Cited by 93
Chen, Q., Muramoto, K., Masaaki, N., Ding, Y., Yang, H., Mackey, M., Li, W., Inoue, Y., Ackermann, K. E., Shirota, H., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00647.x · Cited by 93
The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease
Sabatino, A. D., Battista, N., Biancheri, P., Rapino, C., Rovedatti, L., Astarita, G., Vanoli, A., Dainese, E., Guerci, M., Piomelli, D., et al. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.18 · Cited by 93
Self-citationALOX15 as a suppressor of inflammation and cancer: Lost in the link
Tian, R., Zuo, X., Jaoude, J. C., Mao, F., Colby, J. K., & Shureiqi, I. (2017) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2017.01.002 · Cited by 92
Çınar, R., Gochuico, B. R., Iyer, M. R., Jourdan, T., Yokoyama, T., Park, J. K., Coffey, N. J., Pri‐Chen, H., Szanda, G., Liu, Z., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92281 · Cited by 92
Fabricius, D., Neubauer, M., Mandel, B., Schütz, C., Viardot, A., Vollmer, A., Jahrsdörfer, B., & Debatin, K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902028 · Cited by 90
Wu, S., Wu, X.-H., Lu, C., Dong, L., & Chen, Z. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0184oc · Cited by 90
Reduced 15-lipoxygenase 2 and lipoxin A4/leukotriene B4ratio in children with cystic fibrosis
Ringholz, F., Buchanan, P., Clarke, D., Millar, R. G., McDermott, M., Linnane, B. M., Harvey, B. J., McNally, P., & Urbach, V. (2014) · European Respiratory Journal · doi:10.1183/09031936.00106013 · Cited by 90
Tang, S. J., Wan, M., Huang, W. G., Stanton, R. C., & Xu, Y. (2018) · Mediators of Inflammation · doi:10.1155/2018/2380319 · Cited by 90
Rikkert, M. G. M. O., Verhey, F. R. J., Sijben, J., Bouwman, F. H., DAUTZENBERG, P. L. J., Lansink, M., Sipers, W. M. W. H., van Asselt, D. Z. B., van Hees, A. M. J., Stevens, M., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131892 · Cited by 89
Motyl, J. A., Przykaza, Ł., Boguszewski, P. M., Kossoń, P., & Strosznajder, J. B. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.02.023 · Cited by 89
Missing Pieces to the Endocannabinoid Puzzle
Maccarrone, M. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.11.002 · Cited by 88
Self-citationTsubouchi, Y., Kawahito, Y., Kohno, M., Inoue, K., Hla, T., & Sano, H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4847 · Cited by 87
Valdeolivas, S., Pazos, M. R., Bisogno, T., Piscitelli, F., Iannotti, F. A., Allarà, M., Sagredo, O., Marzo, V. D., & Fernández‐Ruíz, J. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.387 · Cited by 87
Vong, L., Ferraz, J. G., Panaccione, R., Beck, P. L., & Wallace, J. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004982107 · Cited by 87
Regulation of hematogenous tumor metastasis by acid sphingomyelinase
Carpinteiro, A., Becker, K. A., Japtok, L., Hessler, G., Keitsch, S., Požgajová, M., Schmid, K. W., Adams, C., Müller, S. P., Kleuser, B., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404571 · Cited by 87
Persisting eicosanoid pathways in rheumatic diseases
Korotkova, M., & Jakobsson, P. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.1 · Cited by 86
Mattoscio, D., Evangelista, V., CRISTOFARO, R. D., Recchiuti, A., Pandolfi, A., Silvestre, S. D., Manarini, S., Martelli, N., Rocca, B., Petrucci, G., et al. (2010) · The FASEB Journal · doi:10.1096/fj.10-159921 · Cited by 86
Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology
Fan, F., & Roman, R. J. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017030252 · Cited by 86
Kaya, I., Jennische, E., Lange, S., Baykal, A. T., Malmberg, P., & Fletcher, J. S. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14999 · Cited by 86
Necessity of Lysophosphatidic Acid Receptor 1 for Development of Arthritis
Miyabe, Y., Miyabe, C., Iwai, Y., Takayasu, A., Fukuda, S., Yokoyama, W., Nagai, J., Jona, M., Tokuhara, Y., Ohkawa, R., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37991 · Cited by 85
Ceramide Kinase Promotes Tumor Cell Survival and Mammary Tumor Recurrence
Payne, A. W., Pant, D. K., Pan, T.-C., & Chodosh, L. A. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1292 · Cited by 85
A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis
Hernández‐Torres, G., Cipriano, M., Hedén, E., Björklund, E., Canales, Á., Zian, D., Feliú, A., Mecha, M., Guaza, C., Fowler, C. J., et al. (2014) · Angewandte Chemie · doi:10.1002/ange.201407807 · Cited by 85
Filosto, S., Castillo, S., Danielson, A., Franzi, L. M., Khan, E. M., Kenyon, N. J., Last, J. A., Pinkerton, K. E., Tuder, R. M., & Goldkorn, T. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0422oc · Cited by 84
Maihöfner, C., Probst‐Cousin, S., Bergmann, M., Neuhuber, W., Neundörfer, B., & Heuß, D. F. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02879.x · Cited by 84
El‐Remessy, A. B., Rajesh, M., Mukhopadhyay, P., Horváth, B., Patel, V., Al-Gayyar, M. M. H., Pillai, B. A., & Pacher, P. (2011) · Diabetologia · doi:10.1007/s00125-011-2061-4 · Cited by 84
Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice
Costola-de-Souza, C., Ribeiro, A., Ferraz-de-Paula, V., Calefi, A. S., Aloia, T. P. A., Gimenes-Júnior, J. A., de Almeida, V. I., Pinheiro, M. L., & Palermo‐Neto, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077706 · Cited by 83
P53-dependent upregulation of neutral sphingomyelinase-2: role in doxorubicin-induced growth arrest
Shamseddine, A. A., Clarke, C. J., Carroll, B. L., Airola, M. V., Mohammed, S., Rella, A., Obeid, L. M., & Hannun, Y. A. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.268 · Cited by 83
Cannabinoid pharmacology in cancer research: A new hope for cancer patients?
Javid, F. A., Phillips, R. M., Afshinjavid, S., Verde, R., & Ligresti, A. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.02.010 · Cited by 83
Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease
Pardo, A. D., Amico, E., Basit, A., Armirotti, A., Joshi, P. K., Neely, M. D., Vuono, R., Castaldo, S., Digilio, A. F., Scalabrì, F., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05709-y · Cited by 83
Mátyás, C., Erdélyi, K., Trojnár, E., Zhao, S., Varga, Z. V., Pálóczi, J., Mukhopadhyay, P., Németh, B. T., Haskó, G., Çınar, R., et al. (2019) · Hepatology · doi:10.1002/hep.30916 · Cited by 83
Henry, B., Ziobro, R., Becker, K. A., Kolesnick, R., & Gulbins, E. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-7091-1368-4_4 · Cited by 83
Resolvin D1 Reduces Emphysema and Chronic Inflammation
Hsiao, H.-M., Thatcher, T. H., Colas, R. A., Serhan, C. N., Phipps, R. P., & Sime, P. J. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.08.008 · Cited by 82
Józefowski, S., Czerkies, M., Łukasik, A., Bielawska, A. E., Bielawski, J., Kwiatkowska, K., & Sobota, A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902926 · Cited by 82
Adipocyte lipolysis-stimulated interleukin-6 production requires sphingosine kinase 1 activity
Zhang, W., Mottillo, E. P., Zhao, J., Gartung, A., VanHecke, G. C., Lee, J.-F., Maddipati, K. R., Xu, H., Ahn, Y.-H., Proia, R. L., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.601096 · Cited by 80
Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury
Mukhopadhyay, P., Horváth, B., Rajesh, M., Matsumoto, S., Saito, K., Bátkai, S., Patel, V., Tanchian, G., Gao, R. Y., Cravatt, B. F., et al. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.002 · Cited by 80
Mounsey, R. B., Mustafa, S., Robinson, L., Ross, R. A., Riedel, G., Pertwee, R. G., & Teismann, P. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.07.024 · Cited by 79
Stimulation of Sphingosine 1-Phosphate Signaling as an Alveolar Cell Survival Strategy in Emphysema
Diab, K. J., Adamowicz, J. J., Kamocki, K., Rush, N. I., Garrison, J., Gu, Y., Schweitzer, K. S., Skobeleva, A., Gangaraju, R., Hubbard, W. C., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0826oc · Cited by 79
Engel, M. A., Kellermann, C. A., Burnat, G., Hahn, E. G., Rau, T. T., & Konturek, P. C. (2010) · PubMed · Cited by 79
Ryu, J. K., Choi, H. B., & McLarnon, J. G. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.05.043 · Cited by 78
Reprogramming tumor stroma using an endogenous lipid lipoxin A4 to treat pancreatic cancer
Schnittert, J., Heinrich, M. A., Kuninty, P. R., Storm, G., & Prakash, J. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.072 · Cited by 78
Cited by
Soppert, J., Lehrke, M., Marx, N., Jankowski, J., & Noels, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.019 · Cited by 407
The effects of microglia-associated neuroinflammation on Alzheimer’s disease
Wang, C., Zong, S., Cui, X., Wang, X., Wu, S., Wang, L., Liu, Y., & Lu, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1117172 · Cited by 298
Han, X., Wu, X., Liu, F., Chen, H., & Hou, H. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117942 · Cited by 21
The lipid paradox in neuroprogressive disorders: Causes and consequences
Morris, G., Berk, M., Walder, K., O’Neil, A., Maes, M., & Puri, B. K. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.017 · Cited by 17
An iPSC-derived astrocyte model of fragile X syndrome exhibits dysregulated cholesterol homeostasis
Talvio, K., Wagner, V. A., Minkeviciene, R., Kirkwood, J. S., Kulinich, A. O., Umemori, J., Bhatia, A., Hur, M., Käkelä, R., Ethell, I. M., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05147-9 · Cited by 8
Metadata
- Authors
- Leuti, A., Fazio, D., Fava, M., Piccoli, A., Oddi, S., & Maccarrone, M.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2020
- Volume
- 159
- Pages
- 133-169
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W3039772549
- Cited by
- 358
- References
- 617
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.